bupropion hydrochloride (xl) (24979-102)

Drug Facts

Product Profile

Brand Name bupropion hydrochloride (xl)

Generic Name bupropion hydrochloride

Labeler twi pharmaceuticals, inc.

Dosage Form TABLET, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

bupropion hydrochloride 300 mg/1

Manufacturer

TWi Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 24979-102

Product ID 24979-102_98bee4c5-7da0-4607-ab0a-b2af714d41d5

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA210081

Listing Expiration 2026-12-31

Marketing Start 2018-08-30

Pharmacologic Class

Classes

aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24979102

Hyphenated Format 24979-102

Supplemental Identifiers

RxCUI

993541 993557

UNII

ZG7E5POY8O

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (xl) (source: ndc)

Generic Name bupropion hydrochloride (source: ndc)

Application Number ANDA210081 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

300 mg/1

source: ndc

Packaging

500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-02)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-06)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-07)

source: ndc

Packages (3)

24979-102-02 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-02) 24979-102-06 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-06) 24979-102-07 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-07)

Ingredients (1)

bupropion hydrochloride (300 mg/1)

Linked Drug Pages (1)

Bupropion Hydrochloride (XL) ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "98bee4c5-7da0-4607-ab0a-b2af714d41d5", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["cdf6e6d9-28e4-48a8-a5ae-7549b3e1402a"], "manufacturer_name": ["TWi Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-02)", "package_ndc": "24979-102-02", "marketing_start_date": "20180830"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-06)", "package_ndc": "24979-102-06", "marketing_start_date": "20180830"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-07)", "package_ndc": "24979-102-07", "marketing_start_date": "20180830"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "24979-102_98bee4c5-7da0-4607-ab0a-b2af714d41d5", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "24979-102", "generic_name": "bupropion hydrochloride", "labeler_name": "TWi Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210081", "marketing_category": "ANDA", "marketing_start_date": "20180830", "listing_expiration_date": "20261231"}